71 institutions reported holding $46.3M of PMV PHARMACEUTIC (PMVP) in SEC 13F filings for 2026-06-30. Largest institutional holders: BML Capital Management, LLC ($7.1M), TANG CAPITAL MANAGEMENT LLC ($5.7M), Sio Capital Management, LLC ($3.5M), Euclidean Capital LLC ($3.5M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($3.2M). Source: SEC Form 13F.
Source: SEC Form 13F filings · as of 2026-06-30